APA (7th ed.) Citation

Berliba, E., Bogus, M., Vanhoutte, F., Berghmans, P., Good, S. S., Moussa, A., . . . Sommadossi, J. (2019). Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis. Antimicrobial agents and chemotherapy, 63(12), . https://doi.org/10.1128/AAC.01201-19

Chicago Style (17th ed.) Citation

Berliba, Elina, et al. "Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or Without Cirrhosis." Antimicrobial Agents and Chemotherapy 63, no. 12 (2019). https://doi.org/10.1128/AAC.01201-19.

MLA (9th ed.) Citation

Berliba, Elina, et al. "Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or Without Cirrhosis." Antimicrobial Agents and Chemotherapy, vol. 63, no. 12, 2019, https://doi.org/10.1128/AAC.01201-19.